PolyPeptide Group Management
Management criteria checks 2/4
PolyPeptide Group's CEO is Juan Gonzalez, appointed in Apr 2023, has a tenure of 2.17 years. total yearly compensation is €2.71M, comprised of 31.1% salary and 68.9% bonuses, including company stock and options. directly owns 0.69% of the company’s shares, worth €5.13M. The average tenure of the management team and the board of directors is 2.5 years and 4.4 years respectively.
Key information
Juan Gonzalez
Chief executive officer
€2.7m
Total compensation
| CEO salary percentage | 31.11% |
| CEO tenure | 2.2yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.5yrs |
| Board average tenure | 4.4yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | €3m | €842k | -€20m |
| Sep 30 2024 | n/a | n/a | -€24m |
| Jun 30 2024 | n/a | n/a | -€29m |
| Mar 31 2024 | n/a | n/a | -€40m |
| Dec 31 2023 | €2m | €604k | -€51m |
Compensation vs Market: Juan's total compensation ($USD3.11M) is above average for companies of similar size in the German market ($USD1.18M).
Compensation vs Earnings: Juan's compensation has increased whilst the company is unprofitable.
CEO
Juan Gonzalez (53 yo)
Mr. Juan Jose Gonzalez serves as CEO at PolyPeptide Group AG since April 12, 2023. He had been Chief Executive Officer of Ambu A/S since May 15, 2019 until May 20, 2022 and supports the new CEO (Britt Meel...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 2.2yrs | €2.71m | 0.69% € 5.1m | |
| Chief Financial Officer | 1.4yrs | no data | 0.0076% € 56.3k | |
| Director of Global Operations | 2.5yrs | no data | 0.0042% € 31.0k | |
| Director of Corporate Finance | no data | no data | no data | |
| Director of Global Innovation & Technology | no data | no data | no data | |
| Head of Investor Relations & Corporate Communications | no data | no data | no data | |
| Chief Legal Officer & Corporate Secretary | 3.8yrs | no data | no data | |
| Corporate Compliance Manager | no data | no data | no data | |
| Interim Director Global Sales & Marketing | no data | no data | no data | |
| Chief Human Resources Officer | 3.1yrs | no data | no data | |
| Head of Technical Department - Braine | no data | no data | no data | |
| Chief Information Security Officer & Global IT Services VC | no data | no data | no data |
Experienced Management: 8H0's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & Lead Independent Non-Executive Director | 4.4yrs | €238.63k | 0.061% € 450.3k | |
| Non-Executive Chair of the Board of Directors | 4.4yrs | €358.55k | 0.093% € 690.8k | |
| Independent Non-Executive Director | 4.4yrs | €224.89k | 0.067% € 496.8k | |
| Non-Executive & Independent Director | 4.4yrs | €148.98k | 0.078% € 582.6k | |
| Non-Executive Director | 4.4yrs | no data | 0.0097% € 71.9k | |
| Independent Director | less than a year | no data | no data |
Experienced Board: 8H0's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/18 18:56 |
| End of Day Share Price | 2025/06/18 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PolyPeptide Group AG is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Konstantin Wiechert | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Thomas Meyer | Baader Helvea Equity Research |